• Viewed 10,240 times by 3014 users (Last 30 days)
  • print Created with Sketch. Print
RGS
Click for more information
0.00% 12.0¢

REGENEUS LTD

Currently unlisted. watchlist Created with Sketch. Add to my watchlist

Corporate Spotlight

A regenerative medicine company, using stem cell and immuno-oncology technologies to develop a portfolio of cell-based therapies to address unmet medical needs in the human and animal health markets with a focus on osteoarthritis & other musculoskeletal disorders, oncology and dermatology diseases.
View the full Corporate Spotlight arrow Created with Sketch.

Regeneus achieves major milestones

Latest Threads

Tag Subject Date Created with Sketch. Comments Created with Sketch. Views Created with Sketch.
RGS
Still no deal?!? 		18/03/19 54 14K
18/03/19 Last post  findingnemo Comments Created with Sketch.  54  Views Created with Sketch.  14K 
RGS
Ann: Directors Provide $2.5M Loan to Extend Funding Runway 		08/03/19 6 1.4K
08/03/19 Last post  TDA Comments Created with Sketch.  6  Views Created with Sketch.  1.4K 
RGS
Ann: Appendix 4D and Half-Year Report 		28/02/19 0 159
28/02/19 Last post  ASX News Comments Created with Sketch.  0  Views Created with Sketch.  159 
RGS
News: RGS Regeneus Board Provides Loan Funding Of $2.5 Mln 		28/02/19 0 123
28/02/19 Last post  Hot News Comments Created with Sketch.  0  Views Created with Sketch.  123 
RGS
Ann: Response to ASX Appendix 4C Query Letter 		22/02/19 2 748
22/02/19 Last post  zeno9 Comments Created with Sketch.  2  Views Created with Sketch.  748 
RGS
Ann: New CEO Appointed to Accelerate Global Growth 		19/02/19 21 4.5K
19/02/19 Last post  zeno9 Comments Created with Sketch.  21  Views Created with Sketch.  4.5K 
RGS
Ann: Material Terms of Contract for Chief Executive Officer 		01/02/19 1 434
01/02/19 Last post  panorama Comments Created with Sketch.  1  Views Created with Sketch.  434 
RGS
4C 		21:05 0 239
21:05 Last post  bang57 Comments Created with Sketch.  0  Views Created with Sketch.  239 
RGS
Ann: Appendix 4C - Quarterly 		16:11 0 211
16:11 Last post  ASX News Comments Created with Sketch.  0  Views Created with Sketch.  211 
RGS
News: RGS Regeneus Appointed Leo Lee As CEO 		23/01/19 0 187
23/01/19 Last post  Hot News Comments Created with Sketch.  0  Views Created with Sketch.  187 
RGS
Interesting article 		07/12/18 6 1.2K
07/12/18 Last post  Dufrane Comments Created with Sketch.  6  Views Created with Sketch.  1.2K 
RGS
RGS (ASX) Corporate Spotlight Updates 		03/12/18 2 577
03/12/18 Last post  Corporate Spotlight Comments Created with Sketch.  2  Views Created with Sketch.  577 
RGS
Ann: Chinese patent granted for biomarkers for stem cell therapy 		03/12/18 2 937
03/12/18 Last post  happydad Comments Created with Sketch.  2  Views Created with Sketch.  937 
RGS
News: RGS Regeneus Says Chinese Patent Granted For Biomarkers To Monitor Disease Progression For... 		03/12/18 0 152
03/12/18 Last post  Hot News Comments Created with Sketch.  0  Views Created with Sketch.  152 
RGS
Ann: Update on licensing Progenza in Japan 		27/11/18 32 8.2K
27/11/18 Last post  aruc6393 Comments Created with Sketch.  32  Views Created with Sketch.  8.2K 
RGS
Ann: CEO Presentation to 2018 Annual General Meeting 		22/11/18 4 1.0K
22/11/18 Last post  Biotechasx Comments Created with Sketch.  4  Views Created with Sketch.  1.0K 

See All Discussions arrow Created with Sketch.

Corporate Spotlight

Top Stories

This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game

Today, one small pill holds the potential to transform cognitive medicine by addressing conditions like depression and Alzheimer’s. 
Chaos reigns markets – so let's take stock of where we're at ahead of December For many people, it feels like the world has been getting crazier each year since 2020 (or 2016.) It's likely to continue
Watchdog takes Webjet to court over alleged 'false' flight prices with hidden fees The Australian Competition and Consumer Commission has alleged Webjet (ASX:WJL) misled its customers @ and breached consumer law in the process @ by billing its available airfares as cheap but failing to properly disclose compulsory service and booking fees that then had an impact on final prices...
Pro Medicus signs landmark $330M deal to roll out imaging platform in US hospitals Pro Medicus Ltd is set to roll out a suite of diagnostic imaging products across the health care system run by Trinity Health
Southern Cross Gold zooms in on 9 new high-grade zones above 20g/t at Golden Dyke Southern Cross Gold Ltd has found 5.5 metres at 25.4 g/t, with drilling highlighting the presence of multiple zones of mineralisation
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.